MedTrace Logo

Hysterectomy and OPPortunistic SAlpingectomy

NCT03045965 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4400

Last updated 2026-02-17

No results posted yet for this study

Summary

HOPPSA is a register based randomized controlled trial (R-RCT), with the objective to examine if opportunistic salpingectomy compared with no salpingectomy, at the time of hysterectomy for a benign reason

* has no increased risk of complications
* has no negative side effects on ovarian function and subsequent cardiovascular disease or incidence of fractures
* implies reduced risk of subsequent ovarian cancer Randomization and follow-up will be conducted within national registers.

Conditions

Interventions

PROCEDURE

Salpingectomy

The intervention is a routine salpingectomy, performed laparoscopically, through laparotomy or vaginally.

Sponsors & Collaborators

  • Vastra Gotaland Region

    collaborator OTHER_GOV

  • Umeå University

    collaborator OTHER

  • Göteborg University

    lead OTHER

Principal Investigators

  • Annika Strandell · Sahlgrenska University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
54 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2026-06-30
Completion
2053-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03045965 on ClinicalTrials.gov